QUADRAPAX (Acella Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the QUADRAPAX drug offered from Acella Pharmaceuticals, LLC. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Acella Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide |
SUBSTANCE NAME: | PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | ELIXIR |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2011-05-06 |
END MARKETING DATE: | 0000-00-00 |
QUADRAPAX HUMAN PRESCRIPTION DRUG Details:
Item Description | QUADRAPAX from Acella Pharmaceuticals, LLC |
LABELER NAME: | Acella Pharmaceuticals, LLC |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 16.2; .1037; .0194; .0065(mg/5mL; mg/5mL; mg/5mL; mg/5mL) |
START MARKETING DATE: | 2011-05-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42192-520_6eaf0913-2d56-45d7-a430-47d9c1792e84 |
PRODUCT NDC: | 42192-520 |
APPLICATION NUMBER: | |
Other PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: